Organon (OGN) Net Shares Issued and Repurchased (2024)
Organon (OGN) posted Net Shares Issued and Repurchased of $1.5 million for Q4 2024.
Analysis
Organon (OGN) Net Shares Issued and Repurchased (2024) Analysis & Trends
Organon has reported Net Shares Issued and Repurchased for 1 years, with the latest figure at $1.5 million in Q4 2024.
- On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $1.5 million in Q4 2024; TTM through Dec 2024 was $1.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.5 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased was $1.5 million for Q4 2024 at Organon.
- The five-year high for Net Shares Issued and Repurchased was $1.5 million in Q4 2024, with the low at $1.5 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | - |